Although reprogrammed viruses are commonly used in gene therapy to treat diseases, this virus can do its work without affecting healthy cells.
The FDA is coming down hard on pharma following generic drug stalling tactics. This follows the recent publication from the agency of an online list of pharma companies that together have racked up 150 complaints from generics makers seeking samples.
The NIH’s All of Us Research Program issued a funding announcement yesterday for Genome Centres to generate genotype and whole genome sequence data from participants’ biosamples.
Start-up X Genomics has revealed its X Genomics Human Variant Genome Project, which aims to bring together genome specialists to build a genetic data chain powered by the blockchain.
Scientists have successfully developed a far easier way to manipulate different genes by using a common research model, baker’s yeast.
In this open discussion webinar, DNA Genotek and Illumina discuss what’s trending in whole genome sequencing (WGS).
Three years ago a team of scientists built the first synthetic yeast chromosome, and today they have got one giant step closer to their goal of creating a complex organism.
The U.K. Prime Minister, Theresa May has made her first appearance in a series on industrial strategy, whereby she has pledged millions of pounds of government funding to develop artificial intelligence to transform outcomes through early diagnosis of cancer and chronic disease.
Participants covering all aspects of science met at this year’s Genome-Project-write, to discuss how they were going to construct an entire genome from scratch.
Researchers have learned that artificial intelligence resembles the working of a human brain, opening up new possibilities to test how the brain works.